Anti-implantation activity of luteal phase mifepristone administration is not mimicked by prostaglandin synthesis inhibitor or prostaglandin analogue in the rhesus monkey

Contraception

Volumn 55, Issue 2, 1997, Pages 103-114

  Nayak, Nihar Ranjan ^a   Ghosh, Debabrata ^a   Lasley, Bill L ^b   Sengupta, Jayasree ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diclofenac; estradiol; implantation; luteal phase; mCG; mifepristone; misoprostol; progesterone; prostaglandin; rhesus monkey

Indexed keywords

CHORIONIC GONADOTROPIN; DICLOFENAC; ESTRADIOL; MIFEPRISTONE; MISOPROSTOL; PROGESTERONE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; CONTRACEPTION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ESTRADIOL BLOOD LEVEL; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MENSTRUAL CYCLE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROGESTERONE BLOOD LEVEL; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION;

ABORTIFACIENT AGENTS, STEROIDAL; ANIMALS; CHORIONIC GONADOTROPIN; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO IMPLANTATION; ENDOMETRIUM; ESTRADIOL; FEMALE; INJECTIONS, SUBCUTANEOUS; LUTEAL PHASE; MACACA MULATTA; MALE; MENSTRUAL CYCLE; MENSTRUATION-INDUCING AGENTS; MIFEPRISTONE; PREGNANCY; PROGESTERONE; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; PROSTAGLANDINS, SYNTHETIC; RANDOM ALLOCATION;

EID: 0031042380     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(96)00280-6     Document Type: Article

References (39)

1. Van Look PFA, von Hertzen H. Post-ovulatory methods of fertility regulation: the emergence of antiprogestogens. In: Van Look PFA, Perez-Palacios G, eds. Contraceptive research and development 1984 to 1994: the road from Mexico City to Cairo and beyond. Delhi-Bombay-Calcutta-Madras: Oxford University Press, 1994:151-201.
2. Hodgen GD. Pregnancy prevention by intravaginal delivery of a progesterone antagonist: RU486 tampon for menstrual induction and absorption. Fertil Steril 1985; 44:263-7.
3. Schaison G, George M, LeStrat M, Reinberg A, Baulieu EE. Effects of the antiprogesterone steroid RU486 during midluteal phase in normal women. J Clin Endocrinol Metab 1985;61:484-9.
4. Shoupe D, Mishell DR Jr, Lahteenmaki P, et al. Effects of the antiprogesterone RU486 in the normal women. I. Single-dose administration in the midluteal phase. Am J Obstet Gynecol 1987;157:1415-20.
5. Glasier A, Thong KJ, Dewar M, Mackie M, Baird DT. Mifepristone (RU486) compared with high-dose estrogen and progesterone for emergency postcoital contraception. N Engl J Med 1992;327:1041-4.
6. Webb AMC, Russel J, Elstein M. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. Br Med J 1992;305:927-31.
7. Ghosh D, De P, Sengupta J. Luteal phase contraception with mifepristone (RU486) in the rhesus monkey. Indian J Physiol Pharmacol 1994;38:17-22.
8. Li TC, Dockery P, Thomas P, Rosers AW, Lenton EA, Cooke ID. The effects of progesterone receptor blockade in the luteal phase of normal fertile women. Fertil Steril 1988;50:732-42.
9. Greene KE, Kettel LM, Yen SSC. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential. Fertil Steril 1992;58:338-43.
10. Gemzell-Danielsson K, Westlund P, Johannisson E, Swahn ML, Bygdeman M, Seppala M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum Reprod 1996;11:256-64.
11. Psychoyos A, Nikas G, Gravanis A. The role of prostaglandins in blastocyst implantation. Hum Reprod 1995;10(suppl 2):30-42.
12. Inskep EK, Wilson L Jr, Butler WR, Dierschke DJ, Fritz GR, Knobil E. Endometrial secretion of prostaglandins during the ovarian cycle and early pregnancy. In: Kimball FA, ed. The endometrium. Lancaster: MTP Press, 1980:287-309.
13. Abel MH, Baird DT. The effect of 17β-estradiol and progesterone on prostaglandin production by human endometrium maintained in organ culture. Endocrinol 1980;106:1599-1606.
14. Kelly RW, Healy DL, Cameron MJ, Cameron IT, Baird DT. The stimulation of prostaglandin production by two antiprogesterone steroids in human endometrial cells. J Clin Endocrinol Metab 1986;62:1116-23.
15. 2 in separated cells from early human decidua. J Clin Endocrinol Metab 1987;65: 527-34.
16. Norman JE, Wu WX, Kelly RW, Glasier AF, McNeilly AS, Baird DT. Effects of mifepristone in vivo on decidual prostaglandin synthesis and metabolism. Contraception 1991;44:89-98.
17. 2a concentrations. Hum Reprod 1994;9:1626-30.
18. Ghosh D, Sengupta J. Endometrial responses to a deciduogenic stimulus in ovarectomized rhesus monkeys treated with oestrogen and progesterone. J Endocrinol 1989;120:51-8.
19. Sufi SB, Donaldson A, Jeffcoate SL, eds. Method manual. WHO Programme for the Provision of Matched Assay Reagents. Geneva: WHO, 1988:57-83.
20. Munro CJ, Laughlin LA, Dieter J, Hendrickx AG, Lasley BL. An ELISA for the measurement of serum and urinary monkey chorionic gonadotropin concentrations. Am J Primatol (in press).
21. Siegel S, Castellan NJ Jr. Non-parametric statistics for behavioral sciences. New York: McGraw-Hill Book Co., 1988:206-16.
22. Ghosh D, De P, Sengupta J. Contranidatory activity of early luteal phase administration mifepristone in the rhesus monkey. Indian J Physiol Pharmacol 1993;37: 13-8.
23. Yen S, Garzo G, Liu J. Luteal contraception. Contraception 1987;36:13-25.
24. Ferenczy A. Anatomy and histology of the uterine corpus. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. New York: Springer, 1987:257-91.
25. Brenner RM, Maslar IA. The primate oviduct and endometrium. In: Knobil E, Niell JD, eds. The physiology of reproduction, Vol. 1. New York: Raven Press, 1988: 303-29.
26. Finn CA, Pope M. Vascular and cellular changes in the decidualized endometrium of the ovarectomized mouse following cessation of hormone treatment: a possible model for menstruation. J Endocrinol 1984;100:295-300.
27. Cabrol D, Carbonne B, Bienkiewicz A, Dallot A, Alj AE, Cedard L. Induction of labour and cervical maturation using mifepristone (RU486) in the late pregnant rat: influence of a cyclooxygenase inhibitor (diclofenac). Prostaglandins 1991;42:71-9.
28. Glasser SR, Julian J, Decker GL, Tang JP, Carson DD. Development of morphological and functional polarity in primary cultures of immature rat uterine epithelial cells. J Cell Biol 1988;407:2409-23.
29. Psychoyos A, Nikas G, Sarantis L, Gravanis A. Hormonal anti-implants agent: antiprogestins. Hum Reprod 1995;10(suppl 1): 140-50.
30. Kennedy TG. Involvement of local mediators in blastocyst implantation. In: Glasser SR, Mulholland J, Psychoyos A, eds. Endocrinology of embryo-endometrium interaction. New York: Plenum Press, 1994:183-94.
31. Ghosh D, Sengupta J. Prostaglandins and blastocyst implantation in primates. In: Ghosh D, Sengupta J, eds. Cellular and molecular signaling in reproduction. New Delhi: New Age International Ltd., 1996:145-62.
32. Kennedy TG. Evidence for a role for prostaglandins in the initiation of blastocyst implantation in the rat. Biol Reprod 1977;16:289-91.
33. Edwards RG, Brody SA. Implantation and early pregnancy after assisted conception. In: Edwards RG, ed. Principles and practice of assisted human reproduction. Philadelphia: W.B. Saunders Co., 1995:555-605.
34. Brogen RN, Heel RC, Pakes GE, Speight TM, Avery GS. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 1980;20:24-48.
35. Cabrol D, Dallot E, Bienkiewicz A, Alj AE, Sedbon E, Cedard L. Cyclooxygenase and lipoxygenase inhibitors induced changes in the distribution of glycosaminoglycans in the pregnant rat uterine cervix. Prostaglandins 1990;39:515-23.
36. Shoupe D, Mishell DR Jr, Page MA, Madkour H, Spitz JM, Lobo RA. Effects of the antiprogesterone RU486 in normal follicular phase. Am J Obstet Gynecol 1987; 157:1421-6.
37. Batista MC, Cartledge TP, Zellmer AW, Nieman LK, Loriaux DL, Merriam GR. The antiprogestin RU486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles. Fertil Steril 1994;62:28-34.
38. Swahn ML, Johanisson E, Daniore V, de la Torre B, Bygdeman M. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and endometrium. Hum Reprod 1988;3:915-21.
39. Batista MC, Cartledge TP, Zellmer AW, et al. Delayed endometrial maturation induced by daily administration of the antiprogestin RU486: a potential new contraceptive strategy. Am J Obstet Gynecol 1992;167: 60-5.